Brief: Cyclerion Reports Study Results In Patients With Sickle Cell Disease

Korsana Biosciences

14/10/2020 12:16

Oct 14 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION ANNOUNCES PHASE 2 STRONG-SCD STUDY RESULTS IN
PATIENTS
WITH SICKLE CELL DISEASE
    * CYCLERION THERAPEUTICS INC - OLINCIGUAT WAS GENERALLY WELL
TOLERATED ACROSS ALL DOSE RANGES
    * CYCLERION THERAPEUTICS INC - RESULTS DID NOT DEMONSTRATE
ADEQUATE ACTIVITY TO SUPPORT FURTHER INTERNAL CLINICAL
DEVELOPMENT

Source text for Eikon:  ID:nGNX14tS3D 
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))